Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole primary prophylaxis for invasive fungal infection in severe aplastic anemia
ChiCTR-PRC-13003130Phase 4Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voriconazole in invasive mycoses (2 arms), sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoint: Incidence of invasive fungal infection. Started Apr 2013; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR-PRC-13003130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-13003130.